ResearcherUniversitätsmedizin RostockNo recent work listed
Edgar Heinz Uwe Wendt
Matched on OpenAlex author ID A5088879357. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2018: 1 paper · 2019: none · 2020: 2 papers · 2021: none · 2022: 1 paper
Papers 4
- Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism. Co-author DOI 10.1371/journal.pone.0266601↗
- Benefits of non-invasive methods compared to telemetry for distress analysis in a murine model of pancreatic cancer. Co-author DOI 10.1016/j.jare.2019.09.002↗
- Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells. Co-author DOI 10.21873/anticanres.13936↗
- Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells. Co-author DOI 10.3389/fonc.2018.00590↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Dietmar Zechner · 4 shared papers, 2018–2022 · strength 0.50
- Paper Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells. DOI 10.21873/anticanres.13936↗
- Paper Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism. DOI 10.1371/journal.pone.0266601↗
- Paper Benefits of non-invasive methods compared to telemetry for distress analysis in a murine model of pancreatic cancer. DOI 10.1016/j.jare.2019.09.002↗
- Brigitte Vollmar · 4 shared papers, 2018–2022 · strength 0.50
- Paper Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells. DOI 10.21873/anticanres.13936↗
- Paper Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism. DOI 10.1371/journal.pone.0266601↗
- Paper Benefits of non-invasive methods compared to telemetry for distress analysis in a murine model of pancreatic cancer. DOI 10.1016/j.jare.2019.09.002↗
- Maria Schönrogge · 3 shared papers, 2018–2022 · strength 0.38
- Paper Galloflavin Plus Metformin Treatment Impairs Pancreatic Cancer Cells. DOI 10.21873/anticanres.13936↗
- Paper Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism. DOI 10.1371/journal.pone.0266601↗
- Paper Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells. DOI 10.3389/fonc.2018.00590↗
- Xianbin Zhang · 3 shared papers, 2018–2022 · strength 0.34
- Paper Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism. DOI 10.1371/journal.pone.0266601↗
- Paper Benefits of non-invasive methods compared to telemetry for distress analysis in a murine model of pancreatic cancer. DOI 10.1016/j.jare.2019.09.002↗
- Paper Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells. DOI 10.3389/fonc.2018.00590↗
- Simone Kumstel · 3 shared papers, 2018–2022 · strength 0.34
- Paper Targeting pancreatic cancer with combinatorial treatment of CPI-613 and inhibitors of lactate metabolism. DOI 10.1371/journal.pone.0266601↗
- Paper Benefits of non-invasive methods compared to telemetry for distress analysis in a murine model of pancreatic cancer. DOI 10.1016/j.jare.2019.09.002↗
- Paper Blocking Autophagy in Cancer-Associated Fibroblasts Supports Chemotherapy of Pancreatic Cancer Cells. DOI 10.3389/fonc.2018.00590↗
- Tim Schreiber · 1 shared paper, 2022 · strength 0.14
- Robert Jaster · 1 shared paper, 2018 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.